What is PharmEasy?
PharmEasy operates as a comprehensive online pharmacy and healthcare platform based in Mumbai, India. The company serves as a digital bridge between patients and local pharmacies, streamlining the procurement of medications and diagnostic services. By leveraging technology to optimize supply chain logistics and patient access, PharmEasy has established a significant footprint in the healthtech industry. Its market position is defined by its ability to integrate fragmented pharmacy networks into a unified, user-friendly digital ecosystem, thereby enhancing convenience and accessibility for millions of consumers across the region.
How much funding has PharmEasy raised?
PharmEasy has raised a total of $1.5B across 8 funding rounds:
Series A
$5M
Series B
$18M
Series C
$77.4M
Series D
$220M
Multiple Rounds
$1B
Other Financing Round
$216M
Series A (2015): $5M, investors not publicly disclosed
Series B (2017): $18M led by Bessemer Venture Partners, Orios Venture Partners, and Aarin Capital
Series C (2018): $77.4M supported by Think Investments, Trifecta Capital, Orios Venture Partners, F-Prime Capital Partners, Eight Roads Ventures India, Bessemer Venture Partners, JM Financial, Nandan Nilekani, Fundamentum, and Manipal Group
Series D (2019): $220M featuring Temasek
Series E (2021): $350M backed by Temasek, TPG, Think Investments, Prosus Ventures, CDPQ, LGT Lightrock, and Eight Roads Services
Unspecified (2021): $300M with participation from Kotak Group, Temasek, and TPG
Other Financing Round (2021): $350M led by Amansa Capital and ApaH Capital Management
Other Financing Round (2024): $216M, investors not publicly disclosed
Key Investors in PharmEasy
Temasek
Founded in 1974, Temasek is a global investment company headquartered in Singapore. We are a generational investor, seeking to make a difference always with tomorrow in mind.
TPG
TPG is a global alternative asset management firm founded in 1992 with investment strategies spanning private equity, growth equity, impact investing, real estate, market solutions and credit.
Bessemer Venture Partners
Bessemer Venture Partners is a venture capital firm established in 1911, with a global presence and a focus on supporting transformative technology companies.
What's next for PharmEasy?
Looking ahead, PharmEasy is well-positioned to leverage its recent capital injection to further enhance its technological infrastructure and operational efficiency. The company's strategic focus is expected to remain on deepening its penetration within the Indian market while potentially exploring new avenues for service diversification. As the healthtech sector continues to mature, PharmEasy's ability to maintain its growth momentum will likely depend on its capacity to navigate regulatory landscapes and sustain high levels of consumer trust. The continued support from institutional investors suggests a long-term commitment to scaling the platform's impact on healthcare accessibility.
See full PharmEasy company page
